Business Context and Reporting Period
This Form 8-K Current Report was filed by CalciMedica, Inc. on April 26, 2023, with the report date of May 5, 2023. The filing addresses the status of the Company's common stock listing following a delisting determination by Nasdaq and a subsequent trading suspension.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status events rather than financial performance data.
Material Changes
- Nasdaq Delisting: The Company received a final determination from Nasdaq regarding non-compliance with initial listing requirements following a merger transaction. The Company withdrew its appeal on May 1, 2023.
- Trading Venue Upgrade: Following a suspension on March 31, 2023, and initial trading on the Pink Current Information tier on April 3, 2023, the Company's common stock was upgraded to the OTCQB tier on April 26, 2023.
- Trading Symbol: The stock began trading on the OTCQB under the symbol "CALC" on April 26, 2023.
Guidance, Outlook, and Risks
Outlook: The Company maintains an initial listing application with Nasdaq and intends to work diligently to satisfy listing requirements to seek a listing on the Nasdaq Capital Market as soon as possible.
Risks and Contingencies: The filing includes a cautionary statement regarding forward-looking statements. Key risks include the uncertainty of satisfying Nasdaq listing requirements, potential declines in stock price due to the delisting and suspension, and the impact of global financial market fluctuations. The Company assumes no obligation to update these statements except as required by law.
Investor Verification Checklist
- Confirm the current trading status and symbol (CALC) on the OTCQB market.
- Review the Company's progress on its initial listing application with Nasdaq.
- Examine the definitive proxy statement filed on February 9, 2023, and the 2022 Annual Report (Form 10-K) for detailed risk factors and financial data not included in this 8-K.
- Monitor for the filing of Form 25 Notification of Delisting by Nasdaq once internal procedural periods conclude.